Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 45, Issue 10, Pages 2798-2809
Publisher
Wiley
Online
2015-08-08
DOI
10.1002/eji.201545583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy
- (2014) Ghaith Bakdash et al. Expert Review of Clinical Immunology
- The Closely Related CD103+ Dendritic Cells (DCs) and Lymphoid-Resident CD8+ DCs Differ in Their Inflammatory Functions
- (2014) Zhijun Jiao et al. PLoS One
- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
- (2013) J. Tel et al. CANCER RESEARCH
- The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
- (2013) John P Vasilakos et al. Expert Review of Vaccines
- TLR7 Triggering with Polyuridylic Acid Promotes Cross-Presentation in CD8 + Conventional Dendritic Cells by Enhancing Antigen Preservation and MHC Class I Antigen Permanence on the Dendritic Cell Surface
- (2013) M. I. Crespo et al. JOURNAL OF IMMUNOLOGY
- IFN- in the Treatment of Melanoma
- (2012) A. A. Tarhini et al. JOURNAL OF IMMUNOLOGY
- Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity
- (2012) Martin Kreutz et al. PLoS One
- Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
- (2011) P. J. Tacken et al. BLOOD
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
- (2011) Niroshana Anandasabapathy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
- (2011) Marina Caskey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
- (2011) Paul J. Tacken et al. SEMINARS IN IMMUNOLOGY
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC
- (2010) Henning Lauterbach et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
- (2010) S. Mocellin et al. JNCI-Journal of the National Cancer Institute
- TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells
- (2010) Sanna M. Mäkelä et al. MOLECULAR IMMUNOLOGY
- Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation
- (2009) D. Piccioli et al. BLOOD
- Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
- (2009) A. Bonehill et al. CLINICAL CANCER RESEARCH
- Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus
- (2009) Donna L Thibault et al. ARTHRITIS RESEARCH & THERAPY
- Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
- (2008) Olivier Joffre et al. IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now